<?xml version='1.0' encoding='utf-8'?>
<document id="27480864"><sentence text="In Vitro and In Vivo Drug Interaction Study of Two Lead Combinations, Oxantel Pamoate plus Albendazole and Albendazole plus Mebendazole, for the Treatment of Soil-Transmitted Helminthiasis."><entity charOffset="91-102" id="DDI-PubMed.27480864.s1.e0" text="Albendazole" /><entity charOffset="107-118" id="DDI-PubMed.27480864.s1.e1" text="Albendazole" /><entity charOffset="124-135" id="DDI-PubMed.27480864.s1.e2" text="Mebendazole" /><pair ddi="false" e1="DDI-PubMed.27480864.s1.e0" e2="DDI-PubMed.27480864.s1.e0" /><pair ddi="false" e1="DDI-PubMed.27480864.s1.e0" e2="DDI-PubMed.27480864.s1.e1" /><pair ddi="false" e1="DDI-PubMed.27480864.s1.e0" e2="DDI-PubMed.27480864.s1.e2" /><pair ddi="false" e1="DDI-PubMed.27480864.s1.e1" e2="DDI-PubMed.27480864.s1.e1" /><pair ddi="false" e1="DDI-PubMed.27480864.s1.e1" e2="DDI-PubMed.27480864.s1.e2" /></sentence><sentence text="The current treatments against Trichuris trichiura, albendazole and mebendazole, are only poorly efficacious"><entity charOffset="52-63" id="DDI-PubMed.27480864.s2.e0" text="albendazole" /><entity charOffset="68-79" id="DDI-PubMed.27480864.s2.e1" text="mebendazole" /><pair ddi="false" e1="DDI-PubMed.27480864.s2.e0" e2="DDI-PubMed.27480864.s2.e0" /><pair ddi="false" e1="DDI-PubMed.27480864.s2.e0" e2="DDI-PubMed.27480864.s2.e1" /></sentence><sentence text=" Therefore, combination chemotherapy was recommended for treating soil-transmitted helminthiasis" /><sentence text=" Albendazole-mebendazole and albendazole-oxantel pamoate have shown promising results in clinical trials"><entity charOffset="29-56" id="DDI-PubMed.27480864.s4.e0" text="albendazole-oxantel pamoate" /></sentence><sentence text=" However, in vitro and in vivo drug interaction studies should be performed before their simultaneous treatment can be recommended" /><sentence text=" Inhibition of human recombinant cytochromes P450 (CYPs) CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 was tested by exposure to albendazole, albendazole sulfoxide, mebendazole, and oxantel pamoate, as well as albendazole-mebendazole, albendazole sulfoxide-mebendazole, albendazole-oxantel pamoate, and albendazole sulfoxide-oxantel pamoate"><entity charOffset="127-138" id="DDI-PubMed.27480864.s6.e0" text="albendazole" /><entity charOffset="140-161" id="DDI-PubMed.27480864.s6.e1" text="albendazole sulfoxide" /><entity charOffset="163-174" id="DDI-PubMed.27480864.s6.e2" text="mebendazole" /><entity charOffset="180-195" id="DDI-PubMed.27480864.s6.e3" text="oxantel pamoate" /><entity charOffset="220-231" id="DDI-PubMed.27480864.s6.e4" text="mebendazole" /><entity charOffset="255-266" id="DDI-PubMed.27480864.s6.e5" text="mebendazole" /><entity charOffset="268-295" id="DDI-PubMed.27480864.s6.e6" text="albendazole-oxantel pamoate" /><entity charOffset="323-338" id="DDI-PubMed.27480864.s6.e7" text="oxantel pamoate" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e0" e2="DDI-PubMed.27480864.s6.e0" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e0" e2="DDI-PubMed.27480864.s6.e1" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e0" e2="DDI-PubMed.27480864.s6.e2" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e0" e2="DDI-PubMed.27480864.s6.e3" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e0" e2="DDI-PubMed.27480864.s6.e4" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e0" e2="DDI-PubMed.27480864.s6.e5" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e0" e2="DDI-PubMed.27480864.s6.e6" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e0" e2="DDI-PubMed.27480864.s6.e7" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e1" e2="DDI-PubMed.27480864.s6.e1" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e1" e2="DDI-PubMed.27480864.s6.e2" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e1" e2="DDI-PubMed.27480864.s6.e3" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e1" e2="DDI-PubMed.27480864.s6.e4" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e1" e2="DDI-PubMed.27480864.s6.e5" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e1" e2="DDI-PubMed.27480864.s6.e6" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e1" e2="DDI-PubMed.27480864.s6.e7" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e2" e2="DDI-PubMed.27480864.s6.e2" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e2" e2="DDI-PubMed.27480864.s6.e3" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e2" e2="DDI-PubMed.27480864.s6.e4" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e2" e2="DDI-PubMed.27480864.s6.e5" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e2" e2="DDI-PubMed.27480864.s6.e6" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e2" e2="DDI-PubMed.27480864.s6.e7" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e3" e2="DDI-PubMed.27480864.s6.e3" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e3" e2="DDI-PubMed.27480864.s6.e4" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e3" e2="DDI-PubMed.27480864.s6.e5" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e3" e2="DDI-PubMed.27480864.s6.e6" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e3" e2="DDI-PubMed.27480864.s6.e7" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e4" e2="DDI-PubMed.27480864.s6.e4" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e4" e2="DDI-PubMed.27480864.s6.e5" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e4" e2="DDI-PubMed.27480864.s6.e6" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e4" e2="DDI-PubMed.27480864.s6.e7" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e5" e2="DDI-PubMed.27480864.s6.e5" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e5" e2="DDI-PubMed.27480864.s6.e6" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e5" e2="DDI-PubMed.27480864.s6.e7" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e6" e2="DDI-PubMed.27480864.s6.e6" /><pair ddi="false" e1="DDI-PubMed.27480864.s6.e6" e2="DDI-PubMed.27480864.s6.e7" /></sentence><sentence text=" A high-pressure liquid chromatography (HPLC)-UV/visible spectroscopy method was developed and validated for simultaneous quantification of albendazole sulfoxide, albendazole sulfone, mebendazole, and oxantel pamoate in plasma"><entity charOffset="140-161" id="DDI-PubMed.27480864.s7.e0" text="albendazole sulfoxide" /><entity charOffset="163-182" id="DDI-PubMed.27480864.s7.e1" text="albendazole sulfone" /><entity charOffset="184-195" id="DDI-PubMed.27480864.s7.e2" text="mebendazole" /><entity charOffset="201-216" id="DDI-PubMed.27480864.s7.e3" text="oxantel pamoate" /><pair ddi="false" e1="DDI-PubMed.27480864.s7.e0" e2="DDI-PubMed.27480864.s7.e0" /><pair ddi="false" e1="DDI-PubMed.27480864.s7.e0" e2="DDI-PubMed.27480864.s7.e1" /><pair ddi="false" e1="DDI-PubMed.27480864.s7.e0" e2="DDI-PubMed.27480864.s7.e2" /><pair ddi="false" e1="DDI-PubMed.27480864.s7.e0" e2="DDI-PubMed.27480864.s7.e3" /><pair ddi="false" e1="DDI-PubMed.27480864.s7.e1" e2="DDI-PubMed.27480864.s7.e1" /><pair ddi="false" e1="DDI-PubMed.27480864.s7.e1" e2="DDI-PubMed.27480864.s7.e2" /><pair ddi="false" e1="DDI-PubMed.27480864.s7.e1" e2="DDI-PubMed.27480864.s7.e3" /><pair ddi="false" e1="DDI-PubMed.27480864.s7.e2" e2="DDI-PubMed.27480864.s7.e2" /><pair ddi="false" e1="DDI-PubMed.27480864.s7.e2" e2="DDI-PubMed.27480864.s7.e3" /></sentence><sentence text=" Albendazole, mebendazole, oxantel pamoate, albendazole-mebendazole, and albendazole-oxantel pamoate were orally applied to rats (100 mg/kg) and pharmacokinetic parameters calculated"><entity charOffset="1-12" id="DDI-PubMed.27480864.s8.e0" text="Albendazole" /><entity charOffset="14-25" id="DDI-PubMed.27480864.s8.e1" text="mebendazole" /><entity charOffset="27-42" id="DDI-PubMed.27480864.s8.e2" text="oxantel pamoate" /><entity charOffset="73-100" id="DDI-PubMed.27480864.s8.e3" text="albendazole-oxantel pamoate" /><pair ddi="false" e1="DDI-PubMed.27480864.s8.e0" e2="DDI-PubMed.27480864.s8.e0" /><pair ddi="false" e1="DDI-PubMed.27480864.s8.e0" e2="DDI-PubMed.27480864.s8.e1" /><pair ddi="false" e1="DDI-PubMed.27480864.s8.e0" e2="DDI-PubMed.27480864.s8.e2" /><pair ddi="false" e1="DDI-PubMed.27480864.s8.e0" e2="DDI-PubMed.27480864.s8.e3" /><pair ddi="false" e1="DDI-PubMed.27480864.s8.e1" e2="DDI-PubMed.27480864.s8.e1" /><pair ddi="false" e1="DDI-PubMed.27480864.s8.e1" e2="DDI-PubMed.27480864.s8.e2" /><pair ddi="false" e1="DDI-PubMed.27480864.s8.e1" e2="DDI-PubMed.27480864.s8.e3" /><pair ddi="false" e1="DDI-PubMed.27480864.s8.e2" e2="DDI-PubMed.27480864.s8.e2" /><pair ddi="false" e1="DDI-PubMed.27480864.s8.e2" e2="DDI-PubMed.27480864.s8.e3" /></sentence><sentence text=" CYP1A2 showed a 2" /><sentence text="6-fold increased inhibition by albendazole-oxantel pamoate (50% inhibitory concentration [IC50] = 3" /><sentence text="1 μM) and a 3" /><sentence text="9-fold increased inhibition by albendazole sulfoxide-mebendazole (IC50 = 3"><entity charOffset="53-64" id="DDI-PubMed.27480864.s12.e0" text="mebendazole" /></sentence><sentence text="8 μM) compared to the single drugs" /><sentence text=" In rats, mebendazole's area under the concentration-time curve (AUC) and maximal plasma concentration (Cmax) were augmented 3"><entity charOffset="10-23" id="DDI-PubMed.27480864.s14.e0" text="mebendazole's" /></sentence><sentence text="5- and 2" /><sentence text="8-fold, respectively (P = 0" /><sentence text="02 for both) when coadministered with albendazole compared to mebendazole alone"><entity charOffset="38-49" id="DDI-PubMed.27480864.s17.e0" text="albendazole" /><entity charOffset="62-73" id="DDI-PubMed.27480864.s17.e1" text="mebendazole" /><pair ddi="false" e1="DDI-PubMed.27480864.s17.e0" e2="DDI-PubMed.27480864.s17.e0" /><pair ddi="false" e1="DDI-PubMed.27480864.s17.e0" e2="DDI-PubMed.27480864.s17.e1" /></sentence><sentence text=" Albendazole sulfone was slightly affected by albendazole-mebendazole, displaying a 1"><entity charOffset="1-20" id="DDI-PubMed.27480864.s18.e0" text="Albendazole sulfone" /></sentence><sentence text="3-fold-elevated AUC compared to albendazole alone"><entity charOffset="32-43" id="DDI-PubMed.27480864.s19.e0" text="albendazole" /></sentence><sentence text=" Oxantel pamoate could not be quantified, translating to a bioavailability below 0"><entity charOffset="1-16" id="DDI-PubMed.27480864.s20.e0" text="Oxantel pamoate" /></sentence><sentence text="025% in rats" /><sentence text=" Elevated plasma levels of albendazole sulfoxide, albendazole sulfone, and mebendazole in coadministrations are probably not mediated by CYP-based drug-drug interaction"><entity charOffset="27-48" id="DDI-PubMed.27480864.s22.e0" text="albendazole sulfoxide" /><entity charOffset="50-69" id="DDI-PubMed.27480864.s22.e1" text="albendazole sulfone" /><entity charOffset="75-86" id="DDI-PubMed.27480864.s22.e2" text="mebendazole" /><pair ddi="false" e1="DDI-PubMed.27480864.s22.e0" e2="DDI-PubMed.27480864.s22.e0" /><pair ddi="false" e1="DDI-PubMed.27480864.s22.e0" e2="DDI-PubMed.27480864.s22.e1" /><pair ddi="false" e1="DDI-PubMed.27480864.s22.e0" e2="DDI-PubMed.27480864.s22.e2" /><pair ddi="false" e1="DDI-PubMed.27480864.s22.e1" e2="DDI-PubMed.27480864.s22.e1" /><pair ddi="false" e1="DDI-PubMed.27480864.s22.e1" e2="DDI-PubMed.27480864.s22.e2" /></sentence><sentence text=" Even though this study indicates that it is safe to coadminister albendazole-oxantel pamoate and albendazole-mebendazole, human pharmacokinetic studies are recommended"><entity charOffset="66-93" id="DDI-PubMed.27480864.s23.e0" text="albendazole-oxantel pamoate" /></sentence><sentence text="" /></document>